RAS testing in metastatic colorectal cancer: advances in Europe
about
Biomarker in Colorectal Cancer.Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer.Telomere length regulation through epidermal growth factor receptor signaling in cancer.Adequately defining tumor cell proportion in tissue samples for molecular testing improves interobserver reproducibility of its assessment.A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells.Clinical application of targeted next-generation sequencing for colorectal cancer patients: a multicentric Belgian experience.RAS-expanded Mutations and HER2 Expression in Metastatic Colorectal Cancer: A New Step of Precision Medicine
P2860
Q37114675-52AE4D95-DFBE-4AD8-AA36-3E7334300E02Q38860960-30A0F6B2-4648-40B9-9CAD-0C8DA4A948A6Q39455829-2D64CA4D-F53D-40BC-BE77-08224EF02758Q48221075-F463AC93-F8CC-4BF7-89FD-C8E0B5CE7EACQ52731753-A4D497E5-AF05-496A-B28B-5BE9B5DA79DFQ54958714-9F391A18-59FB-4DE6-A938-F9CB0C40C632Q57162471-569B5B2C-8D10-46A1-AC3F-30320C3CB92A
P2860
RAS testing in metastatic colorectal cancer: advances in Europe
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
RAS testing in metastatic colorectal cancer: advances in Europe
@en
type
label
RAS testing in metastatic colorectal cancer: advances in Europe
@en
prefLabel
RAS testing in metastatic colorectal cancer: advances in Europe
@en
P2093
P2860
P921
P1433
P1476
RAS testing in metastatic colorectal cancer: advances in Europe
@en
P2093
Andreas Jung
Etienne Rouleau
Marjolijn J L Ligtenberg
Scott D Patterson
P2860
P2888
P304
P356
10.1007/S00428-015-1876-7
P5008
P577
2015-11-16T00:00:00Z